Israel Englander Cure Vac N.V. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cure Vac N.V. stock. As of the latest transaction made, Millennium Management LLC holds 2,872,919 shares of CVAC stock, worth $9.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,872,919

Previous 2,761,090 4.05%

Holding current value

$9.37 Million

Previous $8.37 Million 16.75%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $258,324 - $558,026	111,829 Added 4.05%	2,872,919 $9.77 Million
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $94,629 - $139,691	32,187 Added 1.18%	2,761,090 $8.37 Million
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $3.35 Million - $5.42 Million	845,244 Added 44.87%	2,728,903 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $624,518 - $1.14 Million	93,351 Added 5.21%	1,883,659 $19.6 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $5.9 Million - $11.6 Million	924,064 Added 106.67%	1,790,308 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $1.9 Million - $2.81 Million	330,212 Added 61.6%	866,244 $5.22 Million
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $13,695 - $27,904	1,831 Added 0.34%	536,032 $4.22 Million
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $589,159 - $867,646	-44,701 Reduced 7.72%	534,201 $7.27 Million
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $5.23 Million - $12.5 Million	355,287 Added 158.88%	578,902 $11.4 Million
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $1.39 Million - $1.99 Million	-41,307 Reduced 15.59%	223,615 $7.67 Million
Q3 2021 Nov 15, 2021	BUY	$49.26 - $74.5 $11.4 Million - $17.3 Million	232,415 Added 714.97%	264,922 $14.5 Million
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $2.32 Million - $5.19 Million	-40,728 Reduced 55.61%	32,507 $2.39 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $4.87 Million - $7.71 Million	61,030 Added 500.04%	73,235 $6.7 Million
Q4 2020 Feb 16, 2021	SELL	$46.76 - $136.27 $13.7 Million - $39.8 Million	-292,432 Reduced 95.99%	12,205 $989,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $77.2 $13.3 Million - $23.5 Million	304,637 New	304,637 $14.2 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

14.4M

Call Options Held

241K

Put Options Held

419K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $611M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account